Effect of ochratoxin A and ochratoxin C on the monocyte and lymphocyte function
Autor: | H. Rosner, Heike Köhler, U. Gräfe, W. Erler, M. Heller, G. Müller |
---|---|
Rok vydání: | 2002 |
Předmět: |
Ochratoxin A
Toxin Lymphocyte Monocyte food and beverages Lymphocyte proliferation Toxicology medicine.disease_cause Microbiology Peripheral blood mononuclear cell Molecular biology chemistry.chemical_compound medicine.anatomical_structure Immune system chemistry Biochemistry medicine Mycotoxin Biotechnology |
Zdroj: | Mycotoxin Research. 18:169-172 |
ISSN: | 0178-7888 |
DOI: | 10.1007/bf02946089 |
Popis: | The effect of practically relevant mycotoxin concentrations on functions of immune cells was studied in in vitro experiments. Porcine mononuclear cells were exposed to a crudeAspergillus-ochraceus toxin containing OTA, a HPLC fraction identical with OTC derived from the crude toxin (RE2), as well as pure OTA and OTC in a concentration range from 0.46 to 3000 ng/ml. The influence of mycotoxin exposure on metabolic activity, mitogen induced proliferation, expression of the activation marker CD25 and the cell cycle of lymphocytes and on the formation of free oxygen radicals as well as the production of the cytokines IL-6 and TNF-α by monocytes was determined. Exposure to high concentrations of all mycotoxin preparations lead to non-specific suppression of the immune cell functions, which was related to cytotoxic effects. Low concentrations caused ambivalent reactions, especially on monocyte function. In general, the HPLC fraction RE2 had an up to 100-fold stronger effect than pure OTA. Ochratoxin-induced suppression of lymphocyte proliferation was not abrogated by phenylalanine or aspartame. The results indicate that immunomodulation can be caused by very low mycotoxin concentrations which are not related to clinical symptoms or loss of performance. |
Databáze: | OpenAIRE |
Externí odkaz: |